Close
Type at least 1 character to search
Back to top

Alon Ben Noon

CEO, NeuroSense Therapeutics

Alon Ben-Noon is co-founder and CEO of NeuroSense Therapeutics, a drug development company focusing on the treatment of ALS and other neurodegenerative diseases.

Show Notes

01:13    Tell us about your career journey and meeting Shay Rishoni

06:25    Tell us about ALS and why it has become a relatively well-known orphan indication

09:30    Tell us about PrimceC

12:40    Could you talk about your financing journey

16:13     Did the crowdfunding process affect your public offering in some sort of way? 

18:54    Is it true that zebrafish have over 70% genetic similarity to humans? How is that even possible?

21:00     Could you expand on the leadership team at NeuroSense? 

23:10    How has your personal life changed since the company was floated to NASDAQ?

25:00   You have a very unique organizational culture in NeuroSense Therapeutics and you're growing.  How do you intend to keep some of that culture while you grow? 

27:30     What’s next forNeuroSense? What are the next milestones and pipeline products?

30:15    How long do you expect you are away from the market with the PrimeC?

31:05  Have you put any thoughts to having a companion diagnostic?

32:25   What are your thoughts about the Israeli ecosystem?

34:25   If you could go back to your 16-year-old self and tell yourself something, what do you think it would be?

35:40  Are there any  people in your journey that were meaningful to you personally and to NeuroSense Therapeutics

Interview Transcription (mild edits)

Coming soon

Links

(More) Amazing people to learn from

Gilad Glick is CEO of Itamar Medical, a company that has change the home testing for sleep.

Liron Fendell is the CEO of Nutritional Growth Solutions, or NGS, that specializes in scientific supplement formulas for children of a small stature. NGS shares are traded on the stock exchange in Australia.

Lena Levin is the co-founder and Via Surgical, the first and only company to create suture-like fixation solutions to address imminent market needs. Her previous venture PolyTouch Medical was acquired back in 2011.

Professor Varda Shalev, a physician, medical researcher, and professor of medicine at Tel Aviv University’s School of Public Health, is also the co-founder of Alike Health.

Dedi Gilad is the CEO of TytoCare, the healthcare industry's first all-in-one modular telehealth device and AI-powered platform for on-demand remote medical exams and visits.

Lihi Segal is the CEO and co-founder of DayTwo. DayTwo provides personalized nutrition and actionable insights that allow you to live healthier and maintain normal blood sugar levels.